Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. - Wikidata - wikimedia - TriplyDB

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

http://www.wikidata.org/entity/Q34084610

about

The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction.A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function Update on myasthenia gravis.Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands.The role of laminins in the organization and function of neuromuscular junctions.Design of new α-conotoxins: from computer modeling to synthesis of potent cholinergic compounds.B cells in the pathophysiology of myasthenia gravis.Ligand-Gated Ion Channels.

P2860

Q34468998-A9B4027C-D0D5-4DAE-BB61-404CAC093712 Q34509316-E2C0722E-5EA3-4312-A316-4CE8E27D9D6E Q35520740-EF243D5E-44C8-4C32-B7AC-936088720EB2 Q35908826-1E88DD87-857B-4312-81CF-22EA79CFAC8B Q36890894-0F5DD287-9A1A-4676-83BF-09EBF47B1C6C Q37378302-E6EB0152-7920-4C45-BDDF-7895003CA8E7 Q38950913-D1A40A20-DBF7-4AF1-A7D1-8A5F4543509F Q38981009-818D4FA8-63BD-4753-8343-6F62644CF7CA Q47756482-E4635C8F-A89D-4E58-8C94-85D51465BBFB Q52803705-9E26229C-DB43-4E03-AA0F-E7CC208D7908

P2860

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

http://www.wikidata.org/entity/Q34084610

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@ast

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@en

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@nl

type

label

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@ast

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@en

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@nl

prefLabel

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@ast

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@en

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@nl

P1433

Q34084610-D1F255C3-AEA7-4802-90F6-0887DFA57EC5

P1476

Q34084610-44DCA9B5-45C8-4179-ADFB-F1B413407F68

P2093

Q34084610-132E4E7B-EE9F-405F-861A-021485669862

Q34084610-8CE52423-DFF9-4B6F-A010-6008125251CB

Q34084610-E38392A5-88A6-450E-9F77-D3CBA642032D

P2860

Q34084610-04DD0843-B702-4EC6-8EA2-4FCEBE31AF53

Q34084610-14F761BF-76E1-4F9D-B20D-58FEE8C5AE95

Q34084610-1C13C682-9A80-4153-859D-3059832DE239

Q34084610-21B30CEE-4F91-43E0-8DD0-CA0055A3EBE7

Q34084610-240B2526-8F69-46C9-9621-DDEF6DF38E2A

Q34084610-2445C4EC-E12C-4590-AC56-EBFCBFE63271

Q34084610-338F9C90-5644-41DE-B563-A442729AB070

Q34084610-37293A0F-1665-41A4-8255-C6BE2704B13C

Q34084610-38FE5E8C-378C-4CAE-B129-838211E3204D

Q34084610-4339394E-9C05-40DC-84FC-D30CCC2DA8F4

P304

Q34084610-487BD845-8B88-4DE1-9E9E-08BB3AB9FED5

P31

Q34084610-567C3482-587F-4457-8498-E544E00BD83F

P356

Q34084610-B85D94FF-7F86-4439-89EF-9BE996613BB5

P407

Q34084610-8E3D317D-3B5E-4F85-BBE6-1C573935FB0C

P433

Q34084610-5F13F3B0-C61C-4C5A-A3A1-53EB3A483664

P478

Q34084610-1512EEAA-FEEE-4212-9BE2-2BC2A8BAF08A

P577

Q34084610-0EE7C009-F8F3-4715-8EB9-2F42EAE7E700

P5875

Q34084610-61EA1BDA-5472-46AA-B0CF-EDADCF19E12F

P698

Q34084610-22B974F4-C1DA-4A00-8177-FD8700E9626B

P356

J.1432-1033.2000.01785.X

P1433

P1476

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.

@en

P2093

A Vincent

http://www.w3.org/2001/XMLSchema#string

B Lang

http://www.w3.org/2001/XMLSchema#string

D Beeson

http://www.w3.org/2001/XMLSchema#string

P2860

Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity

Development of the vertebrate neuromuscular junction

Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome

Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome

Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor.

Congenital myasthenic syndromes: recent advances.

Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells.

P304

6717-6728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1432-1033.2000.01785.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

267

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227899885

http://www.w3.org/2001/XMLSchema#string

P698

11082182

http://www.w3.org/2001/XMLSchema#string